4D pharma to Participate in Upcoming Virtual Investor Conferences in September

Author's Avatar
Sep 09, 2021

4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that 4D pharma management will present at the following virtual investor conferences: